Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


Murat Gültekin

Murat Gültekin

Cancer Control Department, Ministry of Health


Dr. Gultekin is a Gynae Oncologist, an associated Professor and lately a government official, who is actively involved in several leading cancer organizations, such as a council member of the European Society of Gynaecological Oncology (ESGO) and the International Agency for Research on Cancer (IARC) as well as a board member of the Middle East Cancer Consortium, Black Sea Countries Coalition on Breast and Cervical Carcinoma, Women Against Cervical Cancers (WACC), Asian Pacific Organization for Cancer Prevention and Asian National Cancer Centers Alliance (ANCCA). Furthermore, Dr. Gultekin has conducted several Pan-European oncology trials and is engaged in collaboration projects with the World Health Organization (WHO), International Agency for Research on Cancer(IARC), American Cancer Society (ACS) and American Society of Clinical Oncologist (ASCO). As a member of the Turkish Society of Gynaecological Oncology, Dr. Gultekin officially represents the society on foreign affairs and urged the recognition of gynaecological oncology as a subspecialty in Turkey. In addition, Dr. Gultekin is a member of the editorial board of several international cancer journals and prominent oncology textbooks, including ESGO's Textbook of Gynaecological Oncology, a young reviewer for the International Journal of Gynaecological Cancer, author of over 70 articles in SCI indexed publications and has been a member of the organizing committee of many international gynecologic cancers conferences held in Turkey, including ESGO's Istanbul Biennial Meeting in 2005

Research Interest

Gynecological Oncology, female cancers, ovarian cancers, cervical cancers, endometrial cancers, BRCA mutations, sentinel lymph nodes, HPV, cancer epidemiology, palliative care, cancer control programs, cancer screening, cancer epidemiology, clinical trials